Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Longevity Health Hldgs (XAGE)

Longevity Health Hldgs (XAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Longevity Health Hldgs 2403 Sidney Street Suite 300 Pittsburgh PA 15203 USA

www.carmellcorp.com Employees: 15 P: 919-313-9633

INDUSTRY GROUPING:

Consumer Prdts - Misc Discr

Description:

Longevity Health Holdings Inc. operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Longevity Health Holdings Inc., formerly known as Carmell Corporation, is based in Pittsburgh, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 517
Enterprise Value, $K 357
Shares Outstanding, K 1,782
Float, K 1,265
% Float 71.00%
Short Interest, K 3
Short Float 0.18%
Days to Cover 2.39
Short Volume Ratio 0.00
% of Insider Shareholders 29.00%
% of Institutional Shareholders 24.22%

Financials:

Annual Sales, $ 50 K
Annual Net Income, $ -10,370 K
Last Quarter Sales, $ 430 K
Last Quarter Net Income, $ -1,430 K
EBIT, $ -5,760 K
EBITDA, $ -5,540 K

Growth:

1-Year Return -95.97%
3-Year Return -99.90%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 11/14/25
Next Earnings Date 02/27/26 [--]
Earnings Per Share ttm -3.91
EPS Growth vs. Prev Qtr 46.79%
EPS Growth vs. Prev Year 80.26%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 05/14/25

XAGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -193.96%
Profit Margin % -20,740.00%
Debt/Equity 0.00
Price/Sales 1.98
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.24
Interest Coverage -357.33
60-Month Beta 0.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar